| Title: |
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease |
| Authors: |
Müller-Ladner, UlfAff1, IDs40259023006163_cor1; Dignass, AxelAff2; Gaffney, KarlAff3; Jadon, DeepakAff4; Matucci-Cerinic, MarcoAff5, Aff6; Lobaton, TrianaAff7, Aff8; Carron, PhilippeAff9, Aff10, Aff11; Gisbert, Javier P.Aff12; Pande, IraAff13; Utzinger, MaximilianAff14; Addison, JanetAff15 |
| Source: |
BioDrugs. 37(6):873-889 |
| Database: |
Springer Nature Journals |